Last reviewed · How we verify
NCT05424367
Food Environment, Food Insecurity, and Health Behaviors in NH Hispanics
trial in Obesity in 139 participants. Completed in 10 October 2024.
10 October 2024
Quick facts
| Lead sponsor | University of New Hampshire |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 139 |
| Start date | 1 October 2021 |
| Primary completion | 10 October 2024 |
| Estimated completion | 10 October 2024 |
| Sites | 1 location across United States |
Conditions studied
- Obesity — all drugs for Obesity →
- Food Insecurity — all drugs for Food Insecurity →
Sponsor
University of New Hampshire
Who can join
18 and older, any sex, with Obesity or Food Insecurity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This telephone-based survey included adults of Hispanic/Latino background residing in New Hampshire (NH). Information on food security and access, food environment, and health status and behaviors was collected through validated questionnaires. This project addresses the need for assessment of barriers to nutrition and health during COVID-19 in this population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05424367
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other University of New Hampshire trials
Trials by the same sponsor.
- NCT07503912 — Evaluation of the Not A Number Trafficking Prevention Program in Minnesota · NA · not yet recruiting
- NCT05336955 — Evaluation of Telehealth Services on Mental Health Outcomes for People With Intellectual and Developmental Disabilities · NA · recruiting
- NCT05912348 — The Effects of an Obesogenic Lifestyle in Recreationally Active, Young Adults · NA · recruiting
- NCT05488912 — Fiber-rich Foods, Weight Status, and the Gut Microbiota in NH Hispanic Adults at Risk for Food Insecurity · completed
- NCT04760938 — Treating Adolescents With CBT and OBH · NA · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05424367 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of New Hampshire
- Last refreshed: 2 April 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05424367.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing